NCT00545779View on ClinicalTrials.gov

BONCURE Study: A Study of Monthly Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis on Bisphosphonate Therapy.

PHASE3CompletedINTERVENTIONAL
Enrollment

677

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2008

Conditions
Post-Menopausal Osteoporosis
Interventions
DRUG

Ibandronate

150 mg orally once monthly for 6 months

Trial Locations (32)

10000

Zagreb

11000

Belgrade

16059

Bursa

18205

Niška Banja

20020

Denizli

21000

Split

Novi Sad

25240

Erzurum

27310

Gaziantep

34300

Istanbul

34303

Istanbul

35000

Slavonski Brod

35100

Izmir

35340

Istanbul

38039

Kayseri

42080

Konya

45200

Manisa

51000

Rijeka

55139

Samsun

61080

Trabzon

71000

Sarajevo

75000

Tuzla

78000

Banja Luka

81190

Istanbul

Unknown

Tirana

Skopje

71 000

Sarajevo

01330

Adana

06100

Ankara

06550

Ankara

07070

Antalya

09100

Aydin

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT00545779 - BONCURE Study: A Study of Monthly Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis on Bisphosphonate Therapy. | Biotech Hunter | Biotech Hunter